#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Von Hippel-Lindau disease Arterial disorder Wolfram syndrome Kaposi's sarcoma B-cell lymphoma Glycogen storage disease type V Acute lymphocytic leukaemia recurrent Pulmonary hypertension Biotinidase deficiency Myasthenia gravis Non-small cell lung cancer Vulval cancer Anal cancer Extra-osseous Ewing's sarcoma metastatic Breast angiosarcoma metastatic More trials…

    Learn about Rare Diseases

    Lymphatic malformation – Diagnostics Vascular malformation – Life with Disease Noonan syndrome Thrombotic thrombocytopenic purpura – Diagnostics Glycogen storage disease type V – Basic Information Mantle cell lymphoma stage IV – Life with Disease Alternating hemiplegia of childhood – Basic Information Primary immunodeficiency syndrome – Basic Information Nephrotic syndrome – Life with Disease Leukoencephalopathy – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VANADIUM OXIDE SULFATE Haloperidol Decanoate Nusinersen Alendronic Acid VISUGROMAB RNMB3 LY3372993 ABBV-8736 Ds-2325A Ads-015 Lna043 Amisulpride Dnth103 Nadunolimab Resiniferatoxin Cefiderocol Propylene Glycol Lu Ag09222 Vx-670 Pimavanserin Tartrate More therapies…

    Learn about Your Condition

    Langerhans' cell histiocytosis Angina pectoris Microscopic polyangiitis Post-traumatic headache Bone marrow disorder Myelodysplastic syndrome Cleft lip and palate Alcohol abuse Arrhythmia Childhood asthma Bile duct adenocarcinoma Primary hyperoxaluria Triple positive breast cancer Wheezing Pemphigus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study of teclistamab plus autologous lymphocyte infusion in patients with relapsed or refractory multiple myeloma

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Teclistamab
    Italy

  • Comparing human normal immunoglobulin (iv) and a drug combination to prevent infections in adults with B-cell acute lymphoblastic leukemia or B-cell lymphoma treated with CAR-T cells

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell type acute leukaemia
    • B-cell lymphoma
    Investigated Drugs:
    • Amoxicillin Trihydrate
    • Azithromycin
    • Levofloxacin
    France

  • A study of belantamab mafodotin and mezigdomide in patients with relapsed multiple myeloma who have previously received CAR-T cell therapy or bispecific antibodies

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Belantamab Mafodotin
    • Mezigdomide
    France

  • A study of mezigdomide, carfilzomib, and dexamethasone in patients with relapsed or refractory multiple myeloma.

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Mezigdomide
    • Carfilzomib
    • Dexamethasone
    France

  • A study to compare REGN7508 and acetylsalicylic acid for preventing blood clots in adults undergoing elective total knee replacement.

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Regn7508
    • Acetylsalicylic Acid
    Greece Italy Spain

  • A study to evaluate the safety and effectiveness of urokinase, catalytic domain, fused with a single-chain antibody against von Willebrand factor in patients with immune-mediated thrombotic thrombocytopenic purpura.

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Thrombotic microangiopathy
    • Thrombotic thrombocytopenic purpura
    Investigated Drugs:
    • UROKINASE, CATALYTIC DOMAIN, FUSED WITH A SINGLE-CHAIN ANTIBODY AGAINST VON WILLEBRAND FACTOR
    France Germany Italy Spain
Previous Page
1 … 37 38 39 40 41 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!